[
    {
        "@id": "http://purl.org/np/RATL0ZYwMUZe6UCPDsg78mU9NyCPwBwF19_vEHWOgmoYM#Head",
        "@graph": [
            {
                "@id": "http://purl.org/np/RATL0ZYwMUZe6UCPDsg78mU9NyCPwBwF19_vEHWOgmoYM",
                "http://www.nanopub.org/nschema#hasAssertion": [
                    {
                        "@id": "http://purl.org/np/RATL0ZYwMUZe6UCPDsg78mU9NyCPwBwF19_vEHWOgmoYM#assertion"
                    }
                ],
                "http://www.nanopub.org/nschema#hasProvenance": [
                    {
                        "@id": "http://purl.org/np/RATL0ZYwMUZe6UCPDsg78mU9NyCPwBwF19_vEHWOgmoYM#provenance"
                    }
                ],
                "http://www.nanopub.org/nschema#hasPublicationInfo": [
                    {
                        "@id": "http://purl.org/np/RATL0ZYwMUZe6UCPDsg78mU9NyCPwBwF19_vEHWOgmoYM#pubinfo"
                    }
                ],
                "@type": [
                    "http://www.nanopub.org/nschema#Nanopublication"
                ]
            }
        ]
    },
    {
        "@id": "http://purl.org/np/RATL0ZYwMUZe6UCPDsg78mU9NyCPwBwF19_vEHWOgmoYM#pubinfo",
        "@graph": [
            {
                "@id": "http://purl.org/np/RATL0ZYwMUZe6UCPDsg78mU9NyCPwBwF19_vEHWOgmoYM#sig",
                "http://purl.org/nanopub/x/hasAlgorithm": [
                    {
                        "@value": "RSA"
                    }
                ],
                "http://purl.org/nanopub/x/hasPublicKey": [
                    {
                        "@value": "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB"
                    }
                ],
                "http://purl.org/nanopub/x/hasSignature": [
                    {
                        "@value": "cfZWQTQiNlk6ICPV2Q7GO9Lf1V0GGDwZIIfflMKG2X0C6xNpWaAcfG0GObHXJEx8GCPjb9++yJNWuCsZ9awpjOWObcBRkcqn7/xrKlSsNj23DQDDstVh9ThhBx2aH6hAlkKQnkMWzcnsRAFxtQQwahdUDBANKr8hdUb2BaxpUBg="
                    }
                ],
                "http://purl.org/nanopub/x/hasSignatureTarget": [
                    {
                        "@id": "http://purl.org/np/RATL0ZYwMUZe6UCPDsg78mU9NyCPwBwF19_vEHWOgmoYM"
                    }
                ]
            },
            {
                "@id": "http://purl.org/np/RATL0ZYwMUZe6UCPDsg78mU9NyCPwBwF19_vEHWOgmoYM",
                "http://purl.org/dc/terms/created": [
                    {
                        "@value": "2021-08-25T13:54:02.882+02:00",
                        "@type": "http://www.w3.org/2001/XMLSchema#dateTime"
                    }
                ],
                "http://purl.org/dc/terms/creator": [
                    {
                        "@id": "https://orcid.org/0000-0002-1468-3557"
                    }
                ],
                "https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate": [
                    {
                        "@id": "http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM"
                    }
                ],
                "https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate": [
                    {
                        "@id": "http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM"
                    }
                ],
                "https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate": [
                    {
                        "@id": "http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY"
                    }
                ]
            }
        ]
    },
    {
        "@id": "http://purl.org/np/RATL0ZYwMUZe6UCPDsg78mU9NyCPwBwF19_vEHWOgmoYM#provenance",
        "@graph": [
            {
                "@id": "http://purl.org/np/RATL0ZYwMUZe6UCPDsg78mU9NyCPwBwF19_vEHWOgmoYM#assertion",
                "http://www.w3.org/ns/prov#wasAttributedTo": [
                    {
                        "@id": "https://orcid.org/0000-0002-1468-3557"
                    }
                ]
            }
        ]
    },
    {
        "@id": "http://purl.org/np/RATL0ZYwMUZe6UCPDsg78mU9NyCPwBwF19_vEHWOgmoYM#assertion",
        "@graph": [
            {
                "@id": "http://purl.obolibrary.org/obo/DOID_0050700",
                "https://w3id.org/biolink/vocab/category": [
                    {
                        "@id": "https://w3id.org/biolink/vocab/Disease"
                    }
                ]
            },
            {
                "@id": "http://purl.org/np/RATL0ZYwMUZe6UCPDsg78mU9NyCPwBwF19_vEHWOgmoYM#association",
                "http://www.w3.org/1999/02/22-rdf-syntax-ns#object": [
                    {
                        "@id": "http://purl.obolibrary.org/obo/DOID_0050700"
                    }
                ],
                "http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate": [
                    {
                        "@id": "https://w3id.org/biolink/vocab/treats"
                    }
                ],
                "http://www.w3.org/1999/02/22-rdf-syntax-ns#subject": [
                    {
                        "@id": "https://identifiers.org/drugbank:DB00445"
                    }
                ],
                "@type": [
                    "http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement"
                ],
                "http://www.w3.org/2000/01/rdf-schema#label": [
                    {
                        "@value": "\"Patients should not be treated with epirubicin hydrochloride injection if they have any of the following conditions: * cardiomyopathy and/or heart failure, recent myocardial infarction or severe arrhythmias  [see  Warnings and Precautions (5.3 * Previous treatment with maximum cumulative dose of anthracyclines  [see    Warnings and Precautions (5)] . * Hypersensitivity to epirubicin hydrochloride, other anthracyclines, or anthracenediones  [see  Adverse Reactions (6.2)]. Patients should not be treated with epirubicin hydrochloride injection if they have any of the following conditions: baseline neutrophil count < 1500 cells/mm 3; (4).\""
                    }
                ],
                "https://w3id.org/biolink/vocab/provided_by": [
                    {
                        "@id": "https://w3id.org/um/NeuroDKG"
                    }
                ],
                "https://w3id.org/biolink/vocab/relation": [
                    {
                        "@id": "https://schema.org/MedicalContraindication"
                    }
                ]
            },
            {
                "@id": "https://identifiers.org/drugbank:DB00445",
                "https://w3id.org/biolink/vocab/category": [
                    {
                        "@id": "https://w3id.org/biolink/vocab/Drug"
                    }
                ]
            }
        ]
    }
]